卵胞刺激ホルモンの世界市場レポート 2025年

卵胞刺激ホルモン市場規模は、今後数年間で力強い成長が見込まれます。2029年の年間平均成長率（CAGR）は5.4％で、26億4,000万米ドルに成長します。予測期間の成長は、治療用途の拡大、併用療法への需要の高まり、効果的な避妊オプションへのニーズの高まり、高齢化と関連ヘルスケアニーズ、主要地域での市場拡大などに起因します。予測期間における主な動向としては、先進的なバイオシミラーFSH製品、規制当局の承認と市場参入、FSHの生産と送達における技術進歩、効果的な避妊オプションに対するニーズの高まりなどが挙げられます。

卵胞刺激ホルモン市場の予想成長は、不妊症の有病率の増加によって推進されると予想されます。不妊症は、男性または女性の生殖器系に影響を及ぼす病態であり、避妊せずに頻繁に性的接触を12カ月以上続けても妊娠できないことを特徴とします。卵胞刺激ホルモンは、卵巣での卵子の開発を促し、女性では月経周期を調節する上で重要な役割を果たしています。男性では、精巣の成長を促進し、健康な精子細胞の開発をサポートすることで、男性の不妊に不可欠なタンパク質の産生を助けます。特に、2023年4月現在、世界保健機関（WHO）の報告によると、不妊症は世界の成人の約6人に1人が罹患しており、成人人口の約17.5％を占めています。さらに、2023年10月にオーストラリア統計局が発表したデータによると、2022年に記録された出生数は3％減少し、全体の出生率は女性1人当たり1.63人でした。その結果、不妊症の有病率の増加が卵胞刺激ホルモン市場の成長の原動力となっています。

生殖補助医療（ART）の採用が増加していることは、今後数年間における卵胞刺激ホルモン市場の拡大を促進すると予想されます。ARTとは、従来の方法が成功しなかった場合に、個人またはカップルの妊娠を支援する医療処置または実践を指します。ARTにおける卵胞刺激ホルモンの使用は、生殖の課題に直面している人々の妊娠成功の可能性を向上させることを目的とした、確立された治療法です。例えば、2024年3月、米国保健福祉省は、ARTの使用は母親の年齢とともに増加すると報告しています。2023年には、40～45歳の女性の出産数の9％がARTによるもので、45歳以上の女性ではその数は3分の1近くまで上昇しました。その結果、生殖補助医療技術の採用が増加しており、卵胞刺激ホルモン市場に大きな影響を与えています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界卵胞刺激ホルモンPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の卵胞刺激ホルモン市場：成長率分析
• 世界の卵胞刺激ホルモン市場の実績：規模と成長, 2019-2024
• 世界の卵胞刺激ホルモン市場の予測：規模と成長, 2024-2029, 2034F
• 世界卵胞刺激ホルモン総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の卵胞刺激ホルモン市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 組み換えFSH
• 尿中FSH
• 世界の卵胞刺激ホルモン市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 不妊治療
• 生殖補助医療（ART）
• その他の用途
• 世界の卵胞刺激ホルモン市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 不妊治療センター
• 病院
• その他のエンドユーザー
• 世界の卵胞刺激ホルモン市場、組換えFSHのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 純粋組換えFSH
• 混合組換えFSH製剤
• 世界の卵胞刺激ホルモン市場尿中FSHのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 精製尿中FSH
• 尿中FSHと他のホルモンの併用

第7章 地域別・国別分析

• 世界の卵胞刺激ホルモン市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の卵胞刺激ホルモン市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 卵胞刺激ホルモン市場：競合情勢
• 卵胞刺激ホルモン市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • Boehringer Ingelheim GmbH Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Merck KGaA
• Teva Pharmaceutical Industries Ltd.
• Sun Pharmaceutical Industries Ltd.
• Intas Pharmaceuticals Ltd.
• Cipla Ltd.
• Ferring Pharmaceuticals Inc.
• Lupin Limited
• Zydus Lifesciences Limited
• Livzon Pharmaceutical Group Inc.
• Emcure Pharmaceuticals Ltd.
• LG Chem's life sciences
• IBSA Group
• Bharat Serums and Vaccines Limited
• Anhui Anke Biotechnology Group Co. Ltd.
• Taj Pharmaceuticals Ltd.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 卵胞刺激ホルモン市場2029：新たな機会を提供する国
• 卵胞刺激ホルモン市場2029：新たな機会を提供するセグメント
• 卵胞刺激ホルモン市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Follicle-stimulating hormone (FSH) is a hormone secreted by the pituitary gland, playing a crucial role in sexual maturation and reproduction. It influences the functioning of the testicles and ovaries, particularly in regulating egg production in the ovaries and the menstrual cycle.

The primary types of follicle-stimulating hormones include recombinant FSH and urinary FSH. Recombinant FSH is a form of FSH produced using recombinant DNA technology, as opposed to being derived from natural sources such as urine. These hormones find application in various areas, including infertility treatment, assisted reproductive technology (ART), and other medical contexts. They are utilized by diverse end-users, including infertility centers, hospitals, and similar institutions.

The follicle stimulating hormone market research report is one of a series of new reports from The Business Research Company that provides follicle stimulating hormone market statistics, including follicle stimulating hormone industry global market size, regional shares, competitors with a follicle stimulating hormone market share, detailed follicle stimulating hormone market segments, market trends and opportunities, and any further data you may need to thrive in the follicle stimulating hormone industry. This follicle stimulating hormone market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The follicle stimulating hormone market size has grown strongly in recent years. It will grow from $2.03 billion in 2024 to $2.14 billion in 2025 at a compound annual growth rate (CAGR) of 5.4%. The growth in the historic period can be attributed to increased prevalence of hormonal disorders, growing demand for fertility treatment, expansion of FSH indications, market entry of new FSH products, growing demand for safe and effective contraceptive options

The follicle stimulating hormone market size is expected to see strong growth in the next few years. It will grow to $2.64 billion in 2029 at a compound annual growth rate (CAGR) of 5.4%. The growth in the forecast period can be attributed to widening therapeutic applications, rising demand for combination therapy, growing need for effective contraceptive options, aging population and related healthcare needs, market expansion in key regions. Major trends in the forecast period include advanced biosimilar FSH products, regulatory approvals and market access, technological advancements in FSH production and delivery, growing need for effective contraceptive options.

The anticipated growth in the follicle-stimulating hormone market is expected to be propelled by the increasing prevalence of infertility. Infertility, a condition impacting the male or female reproductive system, is characterized by the inability to conceive after 12 months or more of frequent, unprotected sexual contact. Follicle-stimulating hormone plays a crucial role in encouraging egg development in the ovaries and regulating the menstrual cycle in females. In men, it promotes testicular growth and assists in the production of a protein essential for male fertility by supporting the development of healthy sperm cells. Notably, as of April 2023, the World Health Organization reported that infertility affected approximately 1 in 6 adults globally, accounting for around 17.5% of the adult population. Moreover, data from the Australian Bureau of Statistics in October 2023 indicated a 3% decrease in recorded births in 2022, with an overall fertility rate of 1.63 births per woman. Consequently, the increasing prevalence of infertility is a driving force behind the growth of the follicle-stimulating hormone market.

The growing adoption of assisted reproductive technology (ART) is anticipated to drive the expansion of the follicle-stimulating hormone market in the coming years. ART refers to medical procedures or practices that assist individuals or couples in conceiving when traditional methods have not been successful. The use of follicle-stimulating hormone in ART is a well-established therapy aimed at improving the chances of successful pregnancies for those facing reproductive challenges. For example, in March 2024, the U.S. Department of Health and Human Services reported that the use of ART increases with maternal age. In 2023, 9% of live births among women aged 40-45 were achieved through ART, with that number rising to nearly one-third for women aged 45 and older. Additionally, ART usage varies by region across the U.S. As a result, the increasing adoption of assisted reproductive technology is significantly impacting the follicle-stimulating hormone market.

Product innovations are a significant trend gaining traction in the follicle-stimulating hormone market. Leading companies in this sector are concentrating on developing innovative products to enhance their market position. For instance, in July 2024, Proov, a U.S.-based women's health company, introduced the Proov Empower Perimenopause Testing System. Proov Empower provides comprehensive and personalized insights into how a woman's changing hormones impact her overall health and wellness. This non-invasive, multi-time point urine test measures four key hormones-FSH, estrogen marker E1G, progesterone marker PdG, and LH-that affect symptoms and the perimenopause experience. By facilitating periodic retesting, Proov Empower enables women to monitor hormone fluctuations and symptoms, acting as a valuable resource during the transition to menopause.

Major companies in the follicle-stimulating hormone market are also investing in the development of groundbreaking products such as estrogen-based pills to augment their product offerings and gain a competitive edge. Estrogen-based pills, containing the essential hormone for the growth and management of the female reproductive system, represent a notable innovation. In August 2022, Myovant Sciences Ltd., a UK-based biopharmaceutical company, and Pfizer Inc., a US-based pharmaceutical and biotechnology firm, announced the US Food and Drug Administration (FDA) authorization for MYFEMBREE (relugolix 40 mg, estradiol 1 mg, and norethindrone acetate 0.5 mg) as a one-pill treatment. MYFEMBREE serves as a once-daily medication for the treatment of moderate to severe pain caused by endometriosis in premenopausal women for up to 24 months. Additionally, it is authorized for premenopausal women experiencing excessive menstrual bleeding due to uterine fibroids. Myovant and Pfizer intend to jointly market MYFEMBREE in the United States.

In September 2024, Organon China, a healthcare company based in China, partnered with Shanghai Bao Pharmaceutical to develop SJ02, a Long-Acting FSH currently in the BLA process. This innovative investigational asset targets the assisted reproductive technology (ART) market in mainland China. Through this partnership, Organon is advancing its "In China, for China" strategy while expanding its fertility portfolio. By collaborating with leading innovators in China, Organon aims to accelerate advancements in ART and offer additional fertility options to millions of Chinese families. Shanghai Bao Pharmaceutical is a provider of follicle-stimulating hormone (FSH) based in China.

Major companies operating in the follicle stimulating hormone market include Pfizer Inc., Novartis AG, Abbott Laboratories, Sanofi S.A., Boehringer Ingelheim GmbH, Merck KGaA, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Intas Pharmaceuticals Ltd., Cipla Ltd., Ferring Pharmaceuticals Inc., Lupin Limited, Zydus Lifesciences Limited, Livzon Pharmaceutical Group Inc., Emcure Pharmaceuticals Ltd., LG Chem's life sciences, IBSA Group, Bharat Serums and Vaccines Limited, Anhui Anke Biotechnology Group Co. Ltd., Taj Pharmaceuticals Ltd., Genpharm Inc., Cadwell Laboratories Inc., Creative BioMart, Lee Biosolutions Inc., Trumac Healthcare, Midas Pharma GmbH, Biogenix Inc. Pvt. Ltd., Shanghai Techwell Biopharmaceutical Co. Ltd.

North America was the largest region in the follicle stimulating hormone market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the follicle stimulating hormone market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the follicle stimulating hormone market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The follicle-stimulating hormone market consists of sales of luteinizing hormone (LH), chorionic gonadotropin (CG), and thyroid-stimulating hormone. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Follicle Stimulating Hormone Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on follicle stimulating hormone market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for follicle stimulating hormone ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The follicle stimulating hormone market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Recombinant FSH; Urinary FSH
• 2) By Application: Infertility Treatment; Assisted Reproductive Technology (ART); Other Applications
• 3) By End-Users: Infertility Center; Hospitals; Other End-Users
• Subsegments:
• 1) By Recombinant FSH: Pure Recombinant FSH; Mixed Recombinant FSH Formulations
• 2) By Urinary FSH: Purified Urinary FSH; Urinary FSH Combined With Other Hormones
• Companies Mentioned: Pfizer Inc.; Novartis AG; Abbott Laboratories; Sanofi S.A.; Boehringer Ingelheim GmbH
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Follicle Stimulating Hormone Market Characteristics

3. Follicle Stimulating Hormone Market Trends And Strategies

4. Follicle Stimulating Hormone Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Follicle Stimulating Hormone Growth Analysis And Strategic Analysis Framework

• 5.1. Global Follicle Stimulating Hormone PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Follicle Stimulating Hormone Market Growth Rate Analysis
• 5.4. Global Follicle Stimulating Hormone Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Follicle Stimulating Hormone Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Follicle Stimulating Hormone Total Addressable Market (TAM)

6. Follicle Stimulating Hormone Market Segmentation

• 6.1. Global Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Recombinant FSH
• Urinary FSH
• 6.2. Global Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Infertility Treatment
• Assisted Reproductive Technology (ART)
• Other Applications
• 6.3. Global Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Infertility Center
• Hospitals
• Other End-Users
• 6.4. Global Follicle Stimulating Hormone Market, Sub-Segmentation Of Recombinant FSH, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pure Recombinant FSH
• Mixed Recombinant FSH Formulations
• 6.5. Global Follicle Stimulating Hormone Market, Sub-Segmentation Of Urinary FSH, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Purified Urinary FSH
• Urinary FSH Combined With Other Hormones

7. Follicle Stimulating Hormone Market Regional And Country Analysis

• 7.1. Global Follicle Stimulating Hormone Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Follicle Stimulating Hormone Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Follicle Stimulating Hormone Market

• 8.1. Asia-Pacific Follicle Stimulating Hormone Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Follicle Stimulating Hormone Market

• 9.1. China Follicle Stimulating Hormone Market Overview
• 9.2. China Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Follicle Stimulating Hormone Market

• 10.1. India Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Follicle Stimulating Hormone Market

• 11.1. Japan Follicle Stimulating Hormone Market Overview
• 11.2. Japan Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Follicle Stimulating Hormone Market

• 12.1. Australia Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Follicle Stimulating Hormone Market

• 13.1. Indonesia Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Follicle Stimulating Hormone Market

• 14.1. South Korea Follicle Stimulating Hormone Market Overview
• 14.2. South Korea Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Follicle Stimulating Hormone Market

• 15.1. Western Europe Follicle Stimulating Hormone Market Overview
• 15.2. Western Europe Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Follicle Stimulating Hormone Market

• 16.1. UK Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Follicle Stimulating Hormone Market

• 17.1. Germany Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Follicle Stimulating Hormone Market

• 18.1. France Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Follicle Stimulating Hormone Market

• 19.1. Italy Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Follicle Stimulating Hormone Market

• 20.1. Spain Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Follicle Stimulating Hormone Market

• 21.1. Eastern Europe Follicle Stimulating Hormone Market Overview
• 21.2. Eastern Europe Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Follicle Stimulating Hormone Market

• 22.1. Russia Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Follicle Stimulating Hormone Market

• 23.1. North America Follicle Stimulating Hormone Market Overview
• 23.2. North America Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Follicle Stimulating Hormone Market

• 24.1. USA Follicle Stimulating Hormone Market Overview
• 24.2. USA Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Follicle Stimulating Hormone Market

• 25.1. Canada Follicle Stimulating Hormone Market Overview
• 25.2. Canada Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Follicle Stimulating Hormone Market

• 26.1. South America Follicle Stimulating Hormone Market Overview
• 26.2. South America Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Follicle Stimulating Hormone Market

• 27.1. Brazil Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Follicle Stimulating Hormone Market

• 28.1. Middle East Follicle Stimulating Hormone Market Overview
• 28.2. Middle East Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Follicle Stimulating Hormone Market

• 29.1. Africa Follicle Stimulating Hormone Market Overview
• 29.2. Africa Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Follicle Stimulating Hormone Market Competitive Landscape And Company Profiles

• 30.1. Follicle Stimulating Hormone Market Competitive Landscape
• 30.2. Follicle Stimulating Hormone Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Boehringer Ingelheim GmbH Overview, Products and Services, Strategy and Financial Analysis

31. Follicle Stimulating Hormone Market Other Major And Innovative Companies

• 31.1. Merck KGaA
• 31.2. Teva Pharmaceutical Industries Ltd.
• 31.3. Sun Pharmaceutical Industries Ltd.
• 31.4. Intas Pharmaceuticals Ltd.
• 31.5. Cipla Ltd.
• 31.6. Ferring Pharmaceuticals Inc.
• 31.7. Lupin Limited
• 31.8. Zydus Lifesciences Limited
• 31.9. Livzon Pharmaceutical Group Inc.
• 31.10. Emcure Pharmaceuticals Ltd.
• 31.11. LG Chem's life sciences
• 31.12. IBSA Group
• 31.13. Bharat Serums and Vaccines Limited
• 31.14. Anhui Anke Biotechnology Group Co. Ltd.
• 31.15. Taj Pharmaceuticals Ltd.

32. Global Follicle Stimulating Hormone Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Follicle Stimulating Hormone Market

34. Recent Developments In The Follicle Stimulating Hormone Market

35. Follicle Stimulating Hormone Market High Potential Countries, Segments and Strategies

• 35.1 Follicle Stimulating Hormone Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Follicle Stimulating Hormone Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Follicle Stimulating Hormone Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer